# Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.

Study · id `cardio:ct-nct02684812` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02684812](<https://clinicaltrials.gov/study/NCT02684812>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02684812

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 955 participants.

## Technical summary

Registry record NCT02684812. Randomized; single masking; primary purpose treatment. Start 2012-07-16 (actual); primary completion 2019-07-29 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 955 participants (enrolled count; ClinicalTrials.gov record NCT02684812, source copy `cardio:ctgov-nct02684812-2020-11-12`, retrieved 2026-10-31)
- Started: 2012-07-16 (actual) (ClinicalTrials.gov record NCT02684812, source copy `cardio:ctgov-nct02684812-2020-11-12`, retrieved 2026-10-31)
- Primary completion: 2019-07-29 (actual) (ClinicalTrials.gov record NCT02684812, source copy `cardio:ctgov-nct02684812-2020-11-12`, retrieved 2026-10-31)
- Completion: 2020-11-01 (actual) (ClinicalTrials.gov record NCT02684812, source copy `cardio:ctgov-nct02684812-2020-11-12`, retrieved 2026-10-31)
- Countries: Netherlands (ClinicalTrials.gov record NCT02684812, source copy `cardio:ctgov-nct02684812-2020-11-12`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02684812-2020-11-12`, retrieved 2026-10-31)

## The registry's words

- Brief title: Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.
- Acronym: ULTRA
- Condition: Subarachnoid Hemorrhage
- Intervention (Drug): Tranexamic Acid
- Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Lead sponsor class: OTHER
- Collaborator: Stichting Nuts Ohra
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry lists this organization as the lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (`cardio:org-academisch-medisch-centrum-universiteit-van-amsterdam-amc-662d32`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial (`cardio:pubmed-33357465`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA Trial (`cardio:pubmed-36266046`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid Hemorrhage (`cardio:pubmed-38788175`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cost-Effectiveness of Ultra-Early Tranexamic Acid as Add-On to Standard Care After Subarachnoid Hemorrhage (ULTRA Trial) (`cardio:pubmed-40843772`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Quality of life after tranexamic acid in subarachnoid hemorrhage: post-hoc analysis of the ULTRA trial (`cardio:pubmed-42070193`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tranexamic acid after aneurysmal subarachnoid hemorrhage is associated with worse outcome in males: post hoc analysis of the ULTRA trial (`cardio:pubmed-42616160`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a882bfec62bb5f3a1e79a89359d183e5f71cc902803a175d075e8762c3e14a73
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
